Essen. At today's meeting, Evonik's Supervisory Board appointed Mr. Christian Kullmann (45) to the Executive Board of Evonik Industries AG effective July 1, 2014. As Chief Strategic Officer, Kullmann will be responsible for the Corporate Strategy & Corporate Performance, Legal & Compliance, Corporate Affairs, and Corporate Security Divisions.
Werner Müller, Chairman of Evonik's Supervisory Board, commented: "Mr. Kullmann made an enormous contribution to the former RAG and subsequently to preparing Evonik for the capital markets. The company's strategic development in recent years owes much to him and I am delighted that he will now be contributing his considerable experience as a member of the Executive Board."
Klaus Engel, Chairman of Evonik’s Executive Board: "The Executive Board is gaining a long-standing, competent and experienced manager. As a close colleague of mine, Christian Kullmann played a trusted and decisive role in repositioning the Group as a specialty chemicals company and in shaping Evonik's stock exchange listing. We look forward to continuing to work with him as a member of the Executive Board."
On December 1, 2003 Christian Kullmann became Head of Communications & Board Office at the former RAG, from which Evonik was formed in 2007. Prior to that he was Director of Public Relations and Public Affairs at Dresdner Bank. Evonik's Supervisory Board appointed him Executive Vice President effective April 1, 2013.
Evonik, the creative industrial group from Germany, is one of the world leaders
in specialty chemicals. Profitable growth and a sustained increase in the value of the company form the heart of Evonik’s corporate strategy. Its activities focus on the key megatrends health, nutrition, resource efficiency and globalization. Evonik benefits specifically from its innovative prowess and integrated technology platforms.
Evonik is active in over 100 countries around the world. In fiscal 2013 more than 33,500 employees generated sales of around €12.7 billion and an operating profit (adjusted EBITDA) of about €2.0 billion.
In so far as forecasts or expectations are expressed in this Investor Relations News or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.